Target intelligence / Profile preview

Fiber fermentation

Molecular classification
Other
01

Overview

Fiber fermentation is a complex metabolic process primarily occurring in the large intestine, where anaerobic gut microbiota degrade non-digestible dietary carbohydrates (Koh et al., 2016). This biochemical pathway yields short-chain fatty acids (SCFAs), including acetate, propionate, and butyrate, which act as crucial signaling molecules for the host (Blaak et al., 2020). These metabolites interact with specific G protein-coupled receptors, such as Free fatty acid receptor 2 (FFAR2) and Free fatty acid receptor 3 (FFAR3), to regulate immune function, intestinal barrier integrity, and energy homeostasis (Brown et al., 2003; Tolhurst et al., 2012). While fiber fermentation is a physiological process rather than a single molecular target, it is a major focus for therapeutic strategies using prebiotics and probiotics to manage metabolic and inflammatory diseases (Singh et al., 2014). Dysregulation of this process is associated with conditions like inflammatory bowel disease, obesity, and type 2 diabetes, making the modulation of fermentation products a significant area of drug development and nutritional intervention (Morrison & Preston, 2016).

Other names
Colonic fermentationMicrobial carbohydrate fermentationSaccharolytic fermentationDietary fiber metabolism
02

Mechanism of action

Microbial anaerobic degradation of complex carbohydrates into short-chain fatty acids (SCFAs) which subsequently activate host G protein-coupled receptors (GPCRs) such as FFAR2 and FFAR3 to modulate physiological responses (Koh et al., 2016; Brown et al., 2003).

03

Biological functions

MetabolismImmune responseEnergy homeostasisCell signalingIntestinal barrier maintenance
04

Disease associations

Inflammatory bowel diseaseObesityType 2 diabetesColorectal cancerAsthmaCardiovascular disease
05

Safety considerations

Gastrointestinal distress (bloating, flatulence)Osmotic diarrheaPotential for D-lactic acidosis in susceptible individuals
06

Interacting drugs

Inulin

6 more in the full profile.

07

Biomarkers

Fecal short-chain fatty acid concentrationBreath hydrogen levelsGut microbial diversity (16S rRNA)Fecal pH

Beyond the preview

Go deeper on Fiber fermentation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fiber fermentation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call